A

Ampersand Biomedicines

27 employees

Ampersand Biomedicines develops novel programming therapeutics that are designed to act at the sight of disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Biopharma

Date founded

2020

Funding rounds raised

Total raised

$50M

from 1 investors over 1 rounds

A

Ampersand Biomedicines raised $50M on March 7, 2023

Investors: Flagship Ventures

FAQ